Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Haffner

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
The American Journal of Surgical Pathology|June 15, 2018
PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs: An Interclone Evaluation by Differently Trained PathologistsEnrico Munari, Giulio Rossi, Giuseppe Zamboni, et al.
Cancer & Metabolism|September 28, 2018
CD38 is methylated in prostate cancer and regulates extracellular NAD<sup></sup>Jack Mottahedeh, Michael C Haffner, Tristan R Grogan, et al.
Cells|April 26, 2024
Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate CancerDaniel J Turnham, Manisha S Mullen, Nicholas P Bullock, et al.
Journal for Immunotherapy of Cancer|July 1, 2021
TGM4: an immunogenic prostate-restricted antigenZoila A Lopez-Bujanda, Aleksandar Obradovic, Thomas R Nirschl, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategiesSander Frank, Thomas Persse, Ilsa Coleman, et al.
JCO Precision Oncology|April 25, 2024
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to <sup>177</sup>Lu-PSMA-617: A Retrospective Multicenter Cohort StudyRuben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, et al.
Science Advances|October 7, 2022
Oncogenic role of a developmentally regulated <i>NTRK2</i> splice variantSiobhan S Pattwell, Sonali Arora, Nicholas Nuechterlein, et al.
NPJ Precision Oncology|August 15, 2023
An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason gradingYuri Tolkach, Vlado Ovtcharov, Alexey Pryalukhin, et al.
Cancer Research|July 27, 2021
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate CancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Cancer Research|August 22, 2015
Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic ProgressionPaula J Hurley, Robert M Hughes, Brian W Simons, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
The American Journal of Surgical Pathology|June 15, 2018
PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs: An Interclone Evaluation by Differently Trained PathologistsEnrico Munari, Giulio Rossi, Giuseppe Zamboni, et al.
Cancer & Metabolism|September 28, 2018
CD38 is methylated in prostate cancer and regulates extracellular NAD<sup></sup>Jack Mottahedeh, Michael C Haffner, Tristan R Grogan, et al.
Cells|April 26, 2024
Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate CancerDaniel J Turnham, Manisha S Mullen, Nicholas P Bullock, et al.
Journal for Immunotherapy of Cancer|July 1, 2021
TGM4: an immunogenic prostate-restricted antigenZoila A Lopez-Bujanda, Aleksandar Obradovic, Thomas R Nirschl, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategiesSander Frank, Thomas Persse, Ilsa Coleman, et al.
JCO Precision Oncology|April 25, 2024
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to <sup>177</sup>Lu-PSMA-617: A Retrospective Multicenter Cohort StudyRuben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, et al.
Science Advances|October 7, 2022
Oncogenic role of a developmentally regulated <i>NTRK2</i> splice variantSiobhan S Pattwell, Sonali Arora, Nicholas Nuechterlein, et al.
NPJ Precision Oncology|August 15, 2023
An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason gradingYuri Tolkach, Vlado Ovtcharov, Alexey Pryalukhin, et al.
Cancer Research|July 27, 2021
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate CancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Cancer Research|August 22, 2015
Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic ProgressionPaula J Hurley, Robert M Hughes, Brian W Simons, et al.
Pageof 17